TY - JOUR
T1 - Synthesis and characterization of covalent adducts derived from the binding of benzo[a]pyrene diol epoxide to a -ggg- sequence in a deoxyoligonucleotide
AU - Mao, Bing
AU - Xu, Jing
AU - Li, Bin
AU - Margulis, Leonid A.
AU - Smirnov, Sergey
AU - Ya, Nai Qi
AU - Courtney, Scott H.
AU - Geacintov, Nicholas E.
N1 - Funding Information:
This work was supported by the Office of Health and Environmental Research, Department of Energy, under grant DE-FGO2-88ER60674. The Radiation and Solid State Laboratory at New York University is supported by the Department of Energy, grant DE-FGO2-86ER60405. The laser fluorescence lifetime facility is supported by the National Science Foundation Instrumentation and Instrument Development program, award no. 9011268.
PY - 1995/2
Y1 - 1995/2
N2 - Direct synthesis and purification procedures are described for the preparation of adducts derived from the covalent binding of 7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydro-benzo[a]pyrene [(+)-ante-BPDE or (+)-BPDE 2] to each of the three guanine residues (trans-N2 lesions) in the oligodeoxyribonucleotide d(CTATG1G2G3TATC) The positions of the modified Gs are defined by Maxam-Gilbert sequencing techniques. Six different oligonucleotides with one or two precisely positioned (+)-anti-BPDE residues are identified. The absorbance, circular dichroism and fluorescence characteristics are changed upon formation of duplexes with the complementary strands d(GATACCCATAG). In the doubly-modified oligonucleotides, a broad, excimer-like long wavelength fluorescence emission band is observed with a maximum near 455 nm only if the two (+)-anti-BPDE-modified Gs are adjacent to one another. The covalently attached (+)-anti-BPDE residues decrease the thermodynamic stabilities of the duplexes; their melting points are markedly dependent on the position of the lesions, being highest with the (+)-anti-BPDE residue at G1 (Tm=40°C, only 2°C lower than in the case of the unmodified oligonucleotide) and lowest when it is situated at G3 (Tm=29°C). The implications of these and other physical characteristics are discussed. The facile synthesis of these or similar site-specific and stereochemically defined (+)-trans-anti-BPDE-N2-dG lesions in runs of contiguous guanines in oligodeoxyribonucleotides of specified base sequence should be useful for the design of site-directed mutagenesis studies in vitro and in vivo.
AB - Direct synthesis and purification procedures are described for the preparation of adducts derived from the covalent binding of 7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydro-benzo[a]pyrene [(+)-ante-BPDE or (+)-BPDE 2] to each of the three guanine residues (trans-N2 lesions) in the oligodeoxyribonucleotide d(CTATG1G2G3TATC) The positions of the modified Gs are defined by Maxam-Gilbert sequencing techniques. Six different oligonucleotides with one or two precisely positioned (+)-anti-BPDE residues are identified. The absorbance, circular dichroism and fluorescence characteristics are changed upon formation of duplexes with the complementary strands d(GATACCCATAG). In the doubly-modified oligonucleotides, a broad, excimer-like long wavelength fluorescence emission band is observed with a maximum near 455 nm only if the two (+)-anti-BPDE-modified Gs are adjacent to one another. The covalently attached (+)-anti-BPDE residues decrease the thermodynamic stabilities of the duplexes; their melting points are markedly dependent on the position of the lesions, being highest with the (+)-anti-BPDE residue at G1 (Tm=40°C, only 2°C lower than in the case of the unmodified oligonucleotide) and lowest when it is situated at G3 (Tm=29°C). The implications of these and other physical characteristics are discussed. The facile synthesis of these or similar site-specific and stereochemically defined (+)-trans-anti-BPDE-N2-dG lesions in runs of contiguous guanines in oligodeoxyribonucleotides of specified base sequence should be useful for the design of site-directed mutagenesis studies in vitro and in vivo.
UR - http://www.scopus.com/inward/record.url?scp=0028859115&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028859115&partnerID=8YFLogxK
U2 - 10.1093/carcin/16.2.357
DO - 10.1093/carcin/16.2.357
M3 - Article
C2 - 7859369
AN - SCOPUS:0028859115
SN - 0143-3334
VL - 16
SP - 357
EP - 365
JO - Carcinogenesis
JF - Carcinogenesis
IS - 2
ER -